Seeking Alpha

RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly...

RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly traded companies later this year, separating its oncology and gene therapy businesses.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector